Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Seven-time Olympic medalist Shannon Miller was diagnosed with ovarian cancer in her early 30s. More than a decade late, she said women still miss the same key symptoms like bloating and pain.

When cancer cells are physically squeezed, they mount an instant, high-energy defense by rushing mitochondria to the cell nucleus, unleashing a surge of ATP that fuels DNA repair and survival. This ...

Data from an exploratory analysis of the pivotal phase 3 MIRASOL trial (NCT04209855) were recently unveiled at the 2025 European Society for Medical Oncology (ESMO) Congress, opening a broader ...

For decades ovarian cancer has been hard to detect early - often going unnoticed until it reaches advanced stages. But new research at Memorial Sloan Kettering Cancer Center could change that. Dr.